• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Albemarle Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/9/25 4:24:16 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    alb-20250506
    false000091591300009159132025-05-062025-05-060000915913us-gaap:CommonStockMember2025-05-062025-05-060000915913us-gaap:SeriesAPreferredStockMember2025-05-062025-05-06

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _________________________________
    FORM 8-K
    _________________________________

    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 6, 2025

    _________________________________
    ALBEMARLE CORPORATION
    (Exact name of registrant as specified in charter)
    _________________________________
    Virginia001-1265854-1692118
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    4250 Congress Street, Suite 900
    Charlotte, North Carolina 28209
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: (980) 299-5700
    Not applicable
    (Former name or former address, if changed since last report.)
    _________________________________

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    COMMON STOCK, $.01 Par ValueALBNew York Stock Exchange
    DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred StockALB PR ANew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 5.07    Submission of Matters to a Vote of Security Holders.

    On May 6, 2025, the Company held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”). At the Annual Meeting, the proposals listed below were submitted to a vote of the shareholders through the solicitation of proxies. The proposals are described in the definitive proxy statement filed by the Company on March 27, 2025 (the “Proxy Statement”). The voting results for each proposal are set forth below.

    As of the record date for the Annual Meeting, March 12, 2025, there were 117,650,568 shares of common stock outstanding and entitled to vote, of which the holders of 94,234,917 shares of common stock were represented in person or by proxy at the Annual Meeting.


    Proposal 1. Election of directors. The shareholders elected all of the nominees for director to serve for a term expiring at the annual meeting of shareholders in 2026 by the votes set forth in the table below.
    NomineesVoted ForVoted AgainstAbstainBroker Non-Votes
    M. Lauren Brlas79,210,958509,84460,86614,453,249
    Ralf H. Cramer79,130,953585,94564,77014,453,249
    J. Kent Masters, Jr.75,981,6563,738,92361,08914,453,249
    Glenda J. Minor78,312,3271,395,94073,40114,453,249
    James J. O’Brien74,780,2304,937,73263,70614,453,249
    Diarmuid B. O'Connell79,050,716667,52363,42914,453,249
    Dean L. Seavers78,996,137720,98164,55014,453,249
    Gerald A. Steiner76,342,9183,375,02863,72214,453,249
    Holly A. Van Deursen79,288,137434,28759,24414,453,249
    Alejandro D. Wolff75,989,2023,716,04476,42214,453,249


    Proposal 2. Advisory vote on executive compensation. The shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, as set forth in the Proxy Statement, by the votes set forth in the table below.
    Voted ForVoted AgainstAbstainBroker Non-Votes
    54,878,23624,774,734128,69814,453,249


    Proposal 3. Ratification of appointment of independent registered public accounting firm. The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, by the votes set forth in the table below.
    Voted ForVoted AgainstAbstainBroker Non-Votes
    88,993,6415,150,08191,195N/A

    Proposal 4. A shareholder proposal. The shareholders approved the shareholder proposal regarding simple majority vote, by the votes set forth in the table below.
    Voted ForVoted AgainstAbstainBroker Non-Votes
    54,356,65625,139,062285,95014,453,249






    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ALBEMARLE CORPORATION
    Date: May 9, 2025By:/s/ Neal R. Sheorey
    Neal R. Sheorey
    Executive Vice President and Chief Financial Officer


    Get the next $ALB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    2/5/2025Outperform → In-line
    Evercore ISI
    1/28/2025$96.00Hold
    Truist
    1/14/2025$112.00Buy
    Clarksons Platou
    8/5/2024$102.00 → $85.00Outperform → Neutral
    Robert W. Baird
    7/31/2024$160.00 → $83.00Buy → Hold
    Berenberg
    7/17/2024$95.00Buy → Hold
    HSBC Securities
    7/11/2024$145.00 → $100.00Overweight → Equal Weight
    Wells Fargo
    5/22/2024$150.00 → $135.00Sector Outperform → Sector Perform
    Scotiabank
    More analyst ratings

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      12/5/24 7:27:01 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by Albemarle Corporation

      SC 13G - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 12:52:42 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 10:27:59 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Financials

    Live finance-specific insights

    See more
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Reports First Quarter 2025 Results

      CHARLOTTE, N.C., April 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.1 billion, with double-digit volume growth in Specialties (+11%) and record Energy Storage lithium salt production from the company's integrated conversion networkNet income of $41 million, o

      4/30/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Corporation to Release First Quarter 2025 Earnings Results on Wednesday, April 30, 2025

      CHARLOTTE, N.C., April 2, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its first quarter 2025 earnings after the NYSE closes on Wednesday, April 30, 2025. The company will hold a conference call to discuss its first quarter 2025 results on Thursday, May 1, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.albemarle.com.

      4/2/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Reports First Quarter 2025 Results

      CHARLOTTE, N.C., April 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.1 billion, with double-digit volume growth in Specialties (+11%) and record Energy Storage lithium salt production from the company's integrated conversion networkNet income of $41 million, o

      4/30/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Corporation to Release First Quarter 2025 Earnings Results on Wednesday, April 30, 2025

      CHARLOTTE, N.C., April 2, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its first quarter 2025 earnings after the NYSE closes on Wednesday, April 30, 2025. The company will hold a conference call to discuss its first quarter 2025 results on Thursday, May 1, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.albemarle.com.

      4/2/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP, Corporate Controller & CAO Labauve Donald J. Jr. was granted 3,517 shares, increasing direct ownership by 66% to 8,811 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      3/3/25 6:27:12 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Chief People Officer Anderson Melissa H. was granted 5,541 shares, increasing direct ownership by 45% to 17,893 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      3/3/25 6:26:47 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SVP, Ext. Affairs & Comm. Lima Cynthia Renee was granted 7,599 shares, increasing direct ownership by 1,538% to 8,093 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      3/3/25 6:26:21 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Albemarle downgraded by Evercore ISI

      Evercore ISI downgraded Albemarle from Outperform to In-line

      2/5/25 9:17:34 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Truist initiated coverage on Albemarle with a new price target

      Truist initiated coverage of Albemarle with a rating of Hold and set a new price target of $96.00

      1/28/25 7:08:44 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Clarksons Platou initiated coverage on Albemarle with a new price target

      Clarksons Platou initiated coverage of Albemarle with a rating of Buy and set a new price target of $112.00

      1/14/25 7:34:21 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    SEC Filings

    See more
    • Albemarle Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - ALBEMARLE CORP (0000915913) (Filer)

      5/9/25 4:24:16 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SCHEDULE 13G filed by Albemarle Corporation

      SCHEDULE 13G - ALBEMARLE CORP (0000915913) (Subject)

      5/9/25 1:04:11 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form 10-Q filed by Albemarle Corporation

      10-Q - ALBEMARLE CORP (0000915913) (Filer)

      4/30/25 4:35:44 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    See more
    • Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

      Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

      6/19/24 7:00:00 AM ET
      $ALB
      Major Chemicals
      Industrials
    • International Paper Announces Changes to Its Board of Directors

       Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

      5/23/24 10:51:00 AM ET
      $ALB
      $AVNT
      $IP
      Major Chemicals
      Industrials
      Paper
      Basic Materials
    • Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

      CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

      8/2/23 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      11/7/23 4:39:49 PM ET
      $ALB
      Major Chemicals
      Industrials